On September 5th, SHINE Medical Technologies, a company that produces radioisotopes for the purposes of medical testing and cancer therapy, announced it raised $80 million in Series C funding. Fidelity Management and Research Company LLC led the round, along with scores of smaller investors. The investment will go towards building out a medical isotope production facility in Janesville, Wisconsin, a town that has long suffered the effects of deindustrialization and loss of manufacturing jobs.
“This funding round will help SHINE’s continuing efforts to commercialize vital diagnostic and therapeutic isotopes that will be created by our revolutionary, responsible production technologies,” said Greg Piefer, founder and CEO.
What is SHINE?
Founded in 2010, SHINE is working toward be…